Mycophenolate Sodium Delayed-Release Tablets Shortage

• • Mycophenolate sodium oral delayed release tablet, Apotex, 180 mg, bottle, 120 count, NDC 60505-2965-07
  • Mycophenolate sodium oral delayed release tablet, Apotex, 360 mg, bottle, 120 count, NDC 60505-2966-07
  • Mycophenolate sodium oral delayed release tablet, Major, 180 mg, bottle, 30 count, NDC 00904-6785-04
  • Mycophenolate sodium oral delayed release tablet, Major, 180 mg, bottle, 120 count, NDC 00904-6785-61
  • Mycophenolate sodium oral delayed release tablet, Major, 360 mg, bottle, 30 count, NDC 00904-6786-04
  • Mycophenolate sodium oral delayed release tablet, Major, 360 mg, bottle, 120 count, NDC 00904-6786-61

• • Apotex did not provide a reason for the shortage.
  • Major did not provide a reason for the shortage.
  • Mylan has mycophenolate delayed-release tablets available.
  • Novartis has Myfortic delayed-release tablets available.

• • Myfortic oral delayed release tablet, Novartis, 180 mg, bottle, 120 count, NDC 00078-0385-66
  • Myfortic oral delayed release tablet, Novartis, 360 mg, bottle, 120 count, NDC 00078-0386-66
  • Mycophenolate sodium oral delayed release tablet, Mylan, 180 mg, bottle, 100 count, NDC 51079-0508-20
  • Mycophenolate sodium oral delayed release tablet, Mylan, 360 mg, bottle, 100 count, NDC 51079-0509-20

Estimated Resupply Dates

• • Apotex has mycophenolate delayed-release tablets on allocation.
  • Major has mycophenolate delayed-release tablets in 100 count bottles on back order and the company estimates release dates in late-January 2021. The 30 count bottles are also on back order and the company estimates release dates in mid-January 2021.